The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - Amarin (NASDAQ:AMRN) announced on Monday that it is unlikely Vascepa’s regulatory exclusivity will be listed in the August Orange Book supplement, due out in mid-September. … Continue Reading
Read nowLong Ideas - Shares of Sunesis Pharmaceuticals (NASDAQ:SNSS) are rebounding from late losses on Monday, up 50% in premarket trading after the company announced an increase in the … Continue Reading
Read nowLong Ideas - Analysts and investors are refocusing on the opportunity for Pain Therapeutics’ (NASDAQ:PTIE) lead drug candidate, Remoxy. Remoxy is an extended-release formulation of the widely used … Continue Reading
Read nowMost Popular - Cell Therapeutics (NASDAQ:CTIC) closed 10% higher on Monday in anticipation of positive trial data from management at the Rodman & Renshaw Conference in NYC. The … Continue Reading
Read nowMost Popular - A ravenous bull and bear community has developed around Peregrine Pharmaceuticals (NASDAQ:PPHM), and thus far, the bulls have scored big. The company answered most of … Continue Reading
Read nowQuick Picks - Shares of Zalicus Inc. (NASDAQ:ZLCS) sunk 40% before the open Monday morning after the company announced it would be discontinuing development of its Rheumatoid Arthritis … Continue Reading
Read now- Based on an unplanned interim analysis, Geron Corporation (NASDAQ:GERN) announced Monday morning that it will be discontinuing a Phase II study of its developmental drug … Continue Reading
Read now
